1. Impact of new-onset diabetes on clinical outcomes after ST segment-elevated myocardial infarction
- Author
-
Gyo-Seung Hwang, Hyoung-Mo Yang, Kyoung-Woo Seo, Joon-Han Shin, Ji-Yeoun Seo, Myeong-Ho Yoon, Seung-Jea Tahk, Hong-Seok Lim, Byoung-Joo Choi, Jin-Sun Park, and So-Yeon Choi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,030204 cardiovascular system & hematology ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,New onset diabetes ,Recurrence ,Risk Factors ,Diabetes mellitus ,Internal medicine ,Diabetes Mellitus ,Humans ,Medicine ,ST segment ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Aged ,Retrospective Studies ,business.industry ,Mortality rate ,Middle Aged ,medicine.disease ,Progression-Free Survival ,Disease Progression ,Cardiology ,ST Elevation Myocardial Infarction ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Objective. Patients with diabetes have higher mortality rate than patients without diabetes after ST-segment elevated myocardial infarction (STEMI). Prognosis of patients with new onset diabetes (N...
- Published
- 2019
- Full Text
- View/download PDF